HB 1433
In CommitteeHouse
Psychedelic substances
Concerning access to psychedelic substances.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill creates a regulated legal framework in Washington State for adults 21 and older to access psychedelic substances like psilocybin in supervised, therapeutic settings. It establishes licensing for facilitators, service centers, manufacturers, and labs, and creates two new state accounts to fund program operations through fees. The bill emphasizes client safety, confidentiality, equity, and research opportunities.
- Establishes a regulated system allowing adults 21 and older to access psychedelic substances like psilocybin through licensed facilitators, clinical facilitators, and service centers.
- Creates two new licensing frameworks: one under the Department of Health for facilitators and service centers, and one under the Liquor and Cannabis Board for manufacturers and laboratories.
- Requires the Department of Health to develop rules for administration sessions, including preparation, administration, and integration sessions, and to ensure client safety, confidentiality, and equity.
- Provides legal protections for health professionals who advise or counsel clients about psychedelic use, shielding them from adverse licensing actions under state law.
- Establishes strict confidentiality rules for client information, limiting disclosure to third parties unless authorized by the client or required by law.
- Mandates equity considerations in program design, including cost reduction strategies and prioritization of access for historically disadvantaged communities.
Who is affected
- Adult clients seeking psychedelic services — Adults aged 21 and older who wish to access psychedelic substances like psilocybin in a regulated, supervised setting for therapeutic or personal growth purposes.
- Health professionals and facilitators — Health professionals—including therapists, counselors, nurses, and others—who want to provide psychedelic-assisted services and need legal protection and training to do so without risk of professional discipline under current federal drug laws.
- Licensing applicants and business operators — Service center operators, manufacturers, and laboratories that will be licensed to provide, produce, test, and distribute psychedelic substances under state oversight.
- Equity-focused communities — Historically disadvantaged, economically disadvantaged, justice-involved, and disproportionately impacted communities, who are prioritized for equitable access and reduced barriers to services.
- Researchers and academic institutions — Research institutions and scientists, who gain new opportunities to conduct clinical trials and analyze anonymized data on psychedelic use in Washington.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
The bill mandates cost-reduction strategies and prioritization of access for historically disadvantaged communities, aiming to prevent the program from replicating the exclusivity and high costs seen in Oregon and Colorado’s psychedelic programs.
Public SafetyPeopleRef: Sec. 2(f)The bill explicitly protects clients from arrest, prosecution, or loss of parental rights solely for lawful psychedelic use under the program, providing legal certainty and reducing stigma-based discrimination.
Rights & LibertiesPeopleRef: Sec. 56(2)The bill shields health professionals from adverse licensing actions for advising or counseling clients about psychedelic use, removing a major barrier to professional participation and expanding access to informed care.
Rights & LibertiesPeopleRef: Sec. 56(1)The bill establishes a client bill of rights guaranteeing dignity, confidentiality, informed consent, and protection from abuse, enhancing safety and trust in the program.
Public SafetyPeopleRef: Sec. 54The bill prohibits employers from discriminating against employees for lawful psychedelic use outside work absent visible impairment, expanding workplace protections and reducing employment barriers for participants.
Business & EmploymentPeopleRef: Sec. 57
Potential Concerns (5)
The bill preempts local governments from banning psychedelic service centers except in residentially zoned areas and prohibits local taxes/fees on the industry, limiting local control over land use and revenue generation.
Local GovernmentRef: Sec. 50(3)The bill prohibits local governments from imposing proximity restrictions (e.g., buffer zones from schools), removing local authority to tailor land-use policies to community needs and safety concerns.
Local GovernmentRef: Sec. 50(4)The bill allows local governments to set reasonable operating hours but prohibits them from requiring clients to leave during active psychedelic effects, potentially increasing public nuisance risks in neighborhoods near service centers.
Local GovernmentRef: Sec. 50(2)(c)The bill permits local governments to impose reasonable public access restrictions, but the lack of statutory definition creates uncertainty and potential for inconsistent local enforcement.
Local GovernmentRef: Sec. 50(2)(d)The bill declares state law paramount and supersedes inconsistent local ordinances, reducing local autonomy and potentially overriding community values or concerns about psychedelic service proliferation.
Local GovernmentRef: Sec. 48
Who Is Most Affected
Adult clients seeking therapeutic or personal growth benefits from supervised psychedelic services stand to gain significantly, especially those from historically disadvantaged communities prioritized for equitable access. However, low-income clients may still face barriers due to high service costs not covered by insurance.
Health professionals gain legal protection and expanded scope to offer psychedelic-assisted care without fear of professional discipline, but must navigate new training, liability, and ethical responsibilities.
Business operators (service centers, manufacturers, labs) gain new licensing pathways and market opportunities, but must comply with strict regulatory and security requirements that may favor well-capitalized operators.
Equity-focused communities are prioritized in program design, but actual access depends on whether cost-reduction strategies and outreach succeed in overcoming structural barriers.
Researchers gain new opportunities for clinical trials and anonymized data analysis, but data access is limited by strict confidentiality rules and federal restrictions.